ArticleJCO precision oncology2020

Activity of the Highly Specific RET Inhibitor Selpercatinib (LOXO-292) in Pediatric Patients With Tumors Harboring

Michael V Ortiz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.